Nightstar Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for NSR-REP1 in Choroideremia

World News: . []

WALTHAM Mass and LONDON June 14 2018 GLOBE NEWSWIRE) -- Nightstar Therapeutics plc NASDAQNITE a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced that the US Food and Drug Adm inistra...

More news and information about Nightstar Therapeutics

Published By:

Globe Newswire: 11:05 GMT Thursday 14th June 2018

Published: .

Search for other references to "nightstar" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us